Axa S.A. Ideaya Biosciences, Inc. Transaction History

Axa S.A.

$33.6 Billion
Q2 2025

A detailed history of Axa S.A. transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Axa S.A. holds 324,543 shares of IDYA stock, worth $9.81 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

324,543

Previous 324,020 0.16%

Holding current value

$9.81 Million

Previous $5.31 Million 28.53%

% of portfolio

0.02%

Previous 0.02%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$14.5 - $22.63 $7,583 - $11,835	523 Added 0.16%	324,543 $6.82 Million
Q1 2025 May 15, 2025	BUY	$16.38 - $26.0 $1.22 Million - $1.93 Million	74,318 Added 29.76%	324,020 $5.31 Million
Q4 2024 Feb 14, 2025	BUY	$24.79 - $31.98 $1.03 Million - $1.33 Million	41,722 Added 20.06%	249,702 $6.42 Million
Q3 2024 Nov 14, 2024	SELL	$30.37 - $43.05 $1.08 Million - $1.53 Million	-35,504 Reduced 14.58%	207,980 $6.59 Million
Q2 2024 Feb 25, 2025	SELL	$34.37 - $43.46 $213,712 - $270,234	-6,218 Reduced 2.49%	243,484 $8.55 Million
Q2 2024 Aug 14, 2024	BUY	$34.37 - $43.46 $4,674 - $5,910	136 Added 0.06%	243,484 $8.55 Million
Q1 2024 May 15, 2024	BUY	$34.2 - $47.13 $2,325 - $3,204	68 Added 0.03%	243,348 $10.7 Million
Q4 2023 Jul 16, 2024	SELL	$24.59 - $35.83 $1,672 - $2,436	-68 Reduced 0.03%	243,280 $8.66 Million
Q4 2023 Feb 14, 2024	SELL	$24.59 - $35.83 $2.47 Million - $3.6 Million	-100,475 Reduced 29.23%	243,280 $8.66 Million
Q3 2023 Nov 14, 2023	SELL	$21.07 - $29.77 $25,410 - $35,902	-1,206 Reduced 0.35%	343,755 $9.27 Million
Q2 2023 Aug 14, 2023	BUY	$13.33 - $25.53 $63,250 - $121,139	4,745 Added 1.39%	344,961 $8.11 Million
Q1 2023 May 15, 2023	SELL	$13.49 - $18.72 $10,157 - $14,096	-753 Reduced 0.22%	340,216 $4.67 Million
Q4 2022 Feb 14, 2023	SELL	$14.47 - $18.17 $1.28 Million - $1.6 Million	-88,149 Reduced 20.54%	340,969 $6.2 Million
Q3 2022 Feb 14, 2023	BUY	$9.24 - $15.79 $17,278 - $29,527	1,870 Added 0.44%	429,118 $6.4 Million
Q3 2022 Nov 14, 2022	BUY	$9.24 - $15.79 $17,278 - $29,527	1,870 Added 0.44%	429,118 $6.4 Million
Q2 2022 Feb 14, 2023	BUY	$8.28 - $13.88 $1.2 Million - $2.01 Million	145,144 Added 51.45%	427,248 $5.9 Million
Q2 2022 Aug 15, 2022	BUY	$8.28 - $13.88 $1.2 Million - $2.01 Million	145,144 Added 51.45%	427,248 $5.9 Million
Q1 2022 Feb 14, 2023	SELL	$11.18 - $24.02 $1.64 Million - $3.53 Million	-147,014 Reduced 34.26%	282,104 $3.16 Million
Q1 2022 May 13, 2022	BUY	$11.18 - $24.02 $22 - $48	2 Added 0.0%	282,104 $3.16 Million
Q4 2021 Feb 14, 2022	BUY	$20.95 - $26.88 $70,580 - $90,558	3,369 Added 1.21%	282,102 $6.67 Million
Q3 2021 Nov 15, 2021	BUY	$17.26 - $27.08 $666,684 - $1.05 Million	38,626 Added 16.09%	278,733 $7.11 Million
Q2 2021 Aug 13, 2021	BUY	$17.76 - $24.83 $4.26 Million - $5.96 Million	240,107 New	240,107 $5.04 Million

Others Institutions Holding IDYA

# of Institutions

225

Shares Held

84.6M

Call Options Held

28.7K

Put Options Held

132K

View Full List

About IDEAYA Biosciences, Inc.

Ticker IDYA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,067,700
Market Cap $1.45B
Description
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...

More about IDYA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Account